Overview of the major clinical trials investigating stem cells–based therapies for diabetes

Key Points

• Stem cell therapies may enhance insulin production in diabetes, leading to better disease management.
• Multiple clinical trials demonstrate varying degrees of success with beta cell regeneration, particularly in Type 1 diabetes.
• Evaluation of clinical trial data across different interventions has been conducted to identify optimal protocols for treatment.
• Findings underscore the need for further research to validate these therapies in diverse diabetes populations.